High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma by Hill, SL, Sugiyarto, G, Harrington, J, James, E, Underwood, TJ, Elliott, T

Stable, fluorescent markers for tracking synthetic communities and assembly dynamics by Jorrin, B, Haskett, TL, Knights, HE, Martyn, A, Underwood, TJ, Dolliver, J, Ledermann, R, Poole, PS

Multicenter, prospective cohort study of oesophageal injuries and related clinical outcomes (MUSOIC study) by Owen, RP, Chidambaram, S, Griffiths, EA, Sultan, J, Phillips, AW, Vohra, R, Preston, S, Gossage, J, Hanna, GB, Underwood, TJ, Maynard, N, Markar, SR

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma by Noble, F, Lloyd, MA, Turkington, R, Griffiths, E, O'Donovan, M, O'Neill, JR, Mercer, S, Parsons, SL, Fitzgerald, RC, Underwood, TJ, Occams Consortium

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma by Turkington, RC, Knight, LA, Blayney, JK, Secrier, M, Douglas, R, Parkes, EE, Sutton, EK, Stevenson, L, McManus, D, Halliday, S, McCavigan, AM, Logan, GE, Walker, SM, Steele, CJ, Perner, J, Bornschein, J, MacRae, S, Miremadi, A, McCarron, E, McQuaid, S, Arthur, K, James, JA, Eatock, MM, O'Neill, R, Noble, F, Underwood, TJ, Harkin, DP, Salto-Tellez, M, Fitzgerald, RC, Kennedy, RD, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group